These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38462034)

  • 21. Enhanced clonogenic survival induced by protein tyrosine phosphatase (PTP) inhibition after Cr(VI) exposure is mediated by c-Raf and Ras activity.
    Bae D; Camilli TC; Ha NT; Ceryak S
    Cell Signal; 2009 May; 21(5):727-36. PubMed ID: 19167484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformation-specific inhibitors of activated Ras GTPases reveal limited Ras dependency of patient-derived cancer organoids.
    Wiechmann S; Maisonneuve P; Grebbin BM; Hoffmeister M; Kaulich M; Clevers H; Rajalingam K; Kurinov I; Farin HF; Sicheri F; Ernst A
    J Biol Chem; 2020 Apr; 295(14):4526-4540. PubMed ID: 32086379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet-derived growth factor receptor mediates activation of ras through different signaling pathways in different cell types.
    Satoh T; Fantl WJ; Escobedo JA; Williams LT; Kaziro Y
    Mol Cell Biol; 1993 Jun; 13(6):3706-13. PubMed ID: 8388543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galectin-1 augments Ras activation and diverts Ras signals to Raf-1 at the expense of phosphoinositide 3-kinase.
    Elad-Sfadia G; Haklai R; Ballan E; Gabius HJ; Kloog Y
    J Biol Chem; 2002 Oct; 277(40):37169-75. PubMed ID: 12149263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. K-Ras-PI3K regulates H3K56ac through PCAF to elevate the occurrence and growth of liver cancer.
    Gao X; Cheng Z; Yuan H; Zhao H
    J Cell Physiol; 2020 Apr; 235(4):3905-3915. PubMed ID: 31642074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor.
    Yart A; Laffargue M; Mayeux P; Chretien S; Peres C; Tonks N; Roche S; Payrastre B; Chap H; Raynal P
    J Biol Chem; 2001 Mar; 276(12):8856-64. PubMed ID: 11134009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The phosphatidylinositol 3-phosphate phosphatase myotubularin- related protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+ channel KCa3.1.
    Srivastava S; Li Z; Lin L; Liu G; Ko K; Coetzee WA; Skolnik EY
    Mol Cell Biol; 2005 May; 25(9):3630-8. PubMed ID: 15831468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated Ras induces cytoplasmic vacuolation and non-apoptotic death in glioblastoma cells via novel effector pathways.
    Kaul A; Overmeyer JH; Maltese WA
    Cell Signal; 2007 May; 19(5):1034-43. PubMed ID: 17210246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. K-RAS mutant pancreatic tumors show higher sensitivity to MEK than to PI3K inhibition in vivo.
    Hofmann I; Weiss A; Elain G; Schwaederle M; Sterker D; Romanet V; Schmelzle T; Lai A; Brachmann SM; Bentires-Alj M; Roberts TM; Sellers WR; Hofmann F; Maira SM
    PLoS One; 2012; 7(8):e44146. PubMed ID: 22952903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation.
    Lahlou H; Saint-Laurent N; Estève JP; Eychène A; Pradayrol L; Pyronnet S; Susini C
    J Biol Chem; 2003 Oct; 278(41):39356-71. PubMed ID: 12878607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
    Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
    Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity.
    Toulany M; Baumann M; Rodemann HP
    Mol Cancer Res; 2007 Aug; 5(8):863-72. PubMed ID: 17699110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse tissues that undergo neoplastic progression after K-Ras activation are distinguished by nuclear translocation of phospho-Erk1/2 and robust tumor suppressor responses.
    Parikh N; Shuck RL; Nguyen TA; Herron A; Donehower LA
    Mol Cancer Res; 2012 Jun; 10(6):845-55. PubMed ID: 22532587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation-stimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cells.
    Carón RW; Yacoub A; Mitchell C; Zhu X; Hong Y; Sasazuki T; Shirasawa S; Hagan MP; Grant S; Dent P
    Cell Cycle; 2005 Mar; 4(3):456-64. PubMed ID: 15655348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of phosphatidylinositol 3'-kinase and mammalian target of rapamycin/p70 ribosomal protein S6 kinase in K-Ras-mediated transformation of intestinal epithelial cells.
    Shao J; Evers BM; Sheng H
    Cancer Res; 2004 Jan; 64(1):229-35. PubMed ID: 14729629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insight into the mechanism of allosteric activation of PI3Kα by oncoprotein K-Ras4B.
    Li X; Dai J; Ni D; He X; Zhang H; Zhang J; Fu Q; Liu Y; Lu S
    Int J Biol Macromol; 2020 Feb; 144():643-655. PubMed ID: 31816384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Silico Strategies for Designing of Peptide Inhibitors of Oncogenic K-Ras G12V Mutant: Inhibiting Cancer Growth and Proliferation.
    Ghufran M; Khan HA; Ullah M; Ghufran S; Ayaz M; Siddiq M; Hassan SSU; Bungau S
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RRR-alpha-tocopherol succinate down-regulates oncogenic Ras signaling.
    Donapaty S; Louis S; Horvath E; Kun J; Sebti SM; Malafa MP
    Mol Cancer Ther; 2006 Feb; 5(2):309-16. PubMed ID: 16505104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paris saponin VII inhibits growth of colorectal cancer cells through Ras signaling pathway.
    Li Y; Sun Y; Fan L; Zhang F; Meng J; Han J; Guo X; Zhang D; Zhang R; Yue Z; Mei Q
    Biochem Pharmacol; 2014 Mar; 88(2):150-7. PubMed ID: 24462916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of growth factor-induced Ras signaling in vascular endothelial cells and angiogenesis by 3,3'-diindolylmethane.
    Chang X; Firestone GL; Bjeldanes LF
    Carcinogenesis; 2006 Mar; 27(3):541-50. PubMed ID: 16199440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.